Clopidogrel Bisulfate is primarily indicated for:

Clopidogrel Bisulfate is primarily indicated for the prevention of blood clots. It is an antiplatelet medication that works by inhibiting platelet aggregation. By preventing platelets from clumping together, Clopidogrel reduces the risk of stroke, heart attack, and other cardiovascular events in patients who have conditions that increase the likelihood of blood clots, such as atrial fibrillation, recent heart attack, or stent placement.

The other options do not relate to the pharmacological use of Clopidogrel. Management of depression typically involves antidepressants, treatment of seizures requires anticonvulsants, and managing hypertension often involves antihypertensive drugs. Clopidogrel does not have a role in these conditions, which illustrates why they are not the correct indications for this medication.